Cargando…

Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial

INTRODUCTION: As the role of (neuro)inflammation in depression pathophysiology is emerging, augmentation of antidepressant treatments with anti-inflammatory drugs have shown beneficial results, but not consistently across all studies. Inconsistencies may be due to depression biological and clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zwiep, J.C., Bet, P.M., Rhebergen, D., Nurmohamed, M.T., Vinkers, C.H., Penninx, B.W.J.H., Milaneschi, Y., Lamers, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841030/ https://www.ncbi.nlm.nih.gov/pubmed/36655056 http://dx.doi.org/10.1016/j.bbih.2022.100585

Ejemplares similares

Glucocorticoid Receptor (GR) antagonism as disease-modifying treatment for MDD with childhood trauma: protocol of the RESET-medication randomized controlled trial
por: Linsen, F., et al.
Publicado: (2023)

Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile
por: Penninx, Brenda WJH, et al.
Publicado: (2013)

Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials
por: Marini, Stefano, et al.
Publicado: (2016)

Single nucleotide polymorphisms in C-reactive protein (CRP) predict response to adjunctive celecoxib treatment of resistant bipolar depression
por: Halaris, Angelos, et al.
Publicado: (2023)

Dissection of depression heterogeneity using proteomic clusters
por: van Haeringen, Marije, et al.
Publicado: (2023)

High Kynurenine (a Tryptophan Metabolite) Predicts Remission in Patients with Major Depression to Add-on Treatment with Celecoxib
por: Krause, Daniela, et al.
Publicado: (2017)

Interferon-Induced Transmembrane Protein 3 Shapes an Inflamed Tumor Microenvironment and Identifies Immuno-Hot Tumors
por: Cai, Yun, et al.
Publicado: (2021)

Semi-Mechanistic Model for the Antitumor Response of a Combination Cocktail of Immuno-Modulators in Non-Inflamed (Cold) Tumors
por: Sancho-Araiz, Aymara, et al.
Publicado: (2021)

Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort
por: Foiselle, Marianne, et al.
Publicado: (2022)

Biochemical and immuno-histochemical localization of type IIA procollagen in annulus fibrosus of mature bovine intervertebral disc
por: McAlinden, Audrey, et al.
Publicado: (2021)

One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty – a retrospective cohort study
por: Nurmohamed, F. Ruben H. A., et al.
Publicado: (2021)

Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020)

The MECP2‐TRD domain interacts with the DNMT3A‐ADD domain at the H3‐tail binding site
por: Kunert, Stefan, et al.
Publicado: (2023)

Preferences of young adults on the development of a new digital add-on alcohol intervention for depression treatment: A qualitative study
por: Schouten, Maria J.E., et al.
Publicado: (2023)

Randomized trial of add‐on triheptanoin vs medium chain triglycerides in adults with refractory epilepsy
por: Borges, Karin, et al.
Publicado: (2019)

Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy
por: Borges, Karin, et al.
Publicado: (2020)

Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial
por: Strube, Wolfgang, et al.
Publicado: (2022)

Clinical predictors of treatment response to tiotropium add-on therapy in adult asthmatic patients: From multicenter real-world cohort data in Korea
por: Shim, Ji-Su, et al.
Publicado: (2022)

Celecoxib-Induced Modulation of Colon Cancer CD133 Expression Occurs through AKT Inhibition and Is Monitored by (89)Zr Immuno-PET
por: Jung, Kyung-Ho, et al.
Publicado: (2022)

Dissecting the molecular control of immune cell accumulation in the inflamed joint
por: Prendergast, Catriona T., et al.
Publicado: (2022)

Inflamed Eyes
por: Knaggs, R. Lawford
Publicado: (1894)

Inflamed Dentine
por: Smith, Henry A.
Publicado: (1857)

Inflamed Eyelids
Publicado: (1891)

Inflamed Eyelids
Publicado: (1891)

Heterogeneity in depressive and anxiety symptoms and loneliness during the COVID-19 pandemic: Results from three Dutch psychiatric case-control cohorts from April 2020 to February 2022
por: Klokgieters, Silvia S., et al.
Publicado: (2023)

CD4(+) T Cell Interstitial Migration Controlled by Fibronectin in the Inflamed Skin
por: Fernandes, Ninoshka R. J., et al.
Publicado: (2020)

Celecoxib pharmacogenetics and pediatric adenotonsillectomy: a double-blinded randomized controlled study
por: Murto, Kimmo, et al.
Publicado: (2015)

Randomized Controlled Trials of Add-On Antidepressants in Schizophrenia
por: Terevnikov, Viacheslav, et al.
Publicado: (2015)

The ratio and interaction between neurotrophin and immune signaling during electroconvulsive therapy in late-life depression
por: Loef, Dore, et al.
Publicado: (2021)

The Microbiota Profile in Inflamed and Non-Inflamed Ileal Pouch–Anal Anastomosis
por: Kousgaard, Sabrina Just, et al.
Publicado: (2020)

Differences between inflamed and non inflamed appendices diagnosed as acute appendicitis
por: Luiz do Nascimento Junior, Pedro, et al.
Publicado: (2021)

Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts
por: Milaneschi, Yuri, et al.
Publicado: (2021)

Correction: Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts
por: Milaneschi, Yuri, et al.
Publicado: (2021)

Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline—Results From a Randomized Controlled Clinical Trial
por: Simon, Maria S., et al.
Publicado: (2021)

Controlled release of celecoxib inhibits inflammation, bone cysts and osteophyte formation in a preclinical model of osteoarthritis
por: Tellegen, A. R., et al.
Publicado: (2018)

Physically Targeted Intravenous Polyurethane Nanoparticles for Controlled Release of Atorvastatin Calcium
por: Eftekhari, Behnaz Sadat, et al.
Publicado: (2017)

TcellInflamedDetector: an R package to distinguish T cell inflamed tumor types from non–T cell inflamed tumor types
por: Yang, San-Duk, et al.
Publicado: (2022)

Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib
por: Sobolewski, Cyril, et al.
Publicado: (2021)

A self-control training app to increase self-control and reduce aggression – A full factorial design
por: Kip, Hanneke, et al.
Publicado: (2021)

The benefits of inflamed arteries
por: Leslie, Mitch
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_c5h085lb24tvtvbqjpreikrng2